Nabil Lally Represent Quotient Sciences at ASCPT 2025
The American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2025 Annual Meeting in Washington, D.C. marked another significant milestone in the evolution of translational medicine. Gathering researchers, clinicians, and leaders from across the globe, ASCPT 2025 served as a dynamic forum for scientific exchange, collaboration, and insights into the future of drug development. Representing Quotient Sciences , Nabil Lally , Senior Director of Business Development, and Dr . Andreas Reichl , Senior Drug Development Consultant, brought cutting-edge perspectives to this pivotal event. Their participation underscored Quotient Sciences’ commitment to transforming the traditional drug development pathway through its integrated Translational Pharmaceutics platform and consultative, science-led approach to clinical pharmacology. Setting the Stage: Why ASCPT Matters ASCPT is widely recognized as the premier scientific conference in clinical pharmacology, ...